» Articles » PMID: 23737712

The Effect of Mirtazapine on Cisplatin-induced Oxidative Damage and Infertility in Rat Ovaries

Overview
Publisher Wiley
Specialty Biology
Date 2013 Jun 6
PMID 23737712
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Cisplatin causes infertility due to ovarian toxicity. The toxicity mechanism is unknown, but evidence suggests oxidative stress. In this study, the effect of mirtazapine on cisplatin-induced infertility and oxidative stress in rats was investigated. 64 female rats were divided into 4 groups of 16. Except for the controls that received physiologic saline only, all were administered with cisplatin (5 mg/kg i.p.) and mirtazapine (15 mg/kg p.o.) or mirtazapine (30 mg/kg p.o.) for 10 days. After this period, six rats from each group were randomly selected, and malondialdehyde (MDA), myeloperoxidase (MPO), nitric oxide (NO), total gluthatione (tGSH), gluthatione peroxidase (GPx), superoxide dismutase (SOD), and 8-hydroxy-2 deoxyguanine (8-OH Gua) levels were measured in their ovarian tissues. Reproductive functions of the remaining rats were examined for 6 months. The MDA, MPO, NO groups and 8-OH Gua levels were higher in the cisplatin-treated groups than the controls, which was not observed in the mirtazapine and cisplatin groups. GSH, GPx, and SOD levels were reduced by cisplatin, which was prevented by mirtazapine. Cisplatin caused infertility by 70%. The infertility rates were, respectively, 40% and 10% for the 15 and 30 mg/kg mirtazapine administered groups. In conclusion, oxidative stress induced by cisplatin in the rat ovary tissue causes infertility in the female rats. Mirtazapine reverses this in a dose-dependent manner.

Citing Articles

The Relationship Between Oxidative Stress and Infertility Due to Antihypertensive Drugs in Rattus Norvegicus.

Asir B, Kumtepe Y Animals (Basel). 2025; 14(24.

PMID: 39765578 PMC: 11672417. DOI: 10.3390/ani14243674.


Evaluation of the Effect of Different Inhalation Agents on Ovaries with Hyperthermic Intraperitoneal Chemotherapy: An Experimental Study.

Sen O, Aslan E, Kalayci D, Kucuk A, Baskan S, Sezen S Medicina (Kaunas). 2024; 60(9).

PMID: 39336444 PMC: 11434566. DOI: 10.3390/medicina60091403.


An overview of different methods to establish a murine premature ovarian failure model.

Pouladvand N, Azarnia M, Zeinali H, Fathi R, Tavana S Animal Model Exp Med. 2024; 7(6):835-852.

PMID: 39219374 PMC: 11680483. DOI: 10.1002/ame2.12477.


Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage.

Guo Y, Xue L, Tang W, Xiong J, Chen D, Dai Y Hum Reprod Update. 2024; 30(5):614-647.

PMID: 38942605 PMC: 11369228. DOI: 10.1093/humupd/dmae020.


Protective Effect of Glutathione Administration on Ovarian Function in Female Rats with Cyclophosphamide-Induced Ovarian Damage.

Yurttancikmaz E, Ozcan P, Tanoglu F, Tok O, Timur H, Cetin C Gynecol Obstet Invest. 2024; 89(2):120-130.

PMID: 38253037 PMC: 11126202. DOI: 10.1159/000536055.


References
1.
Jordan P, Carmo-Fonseca M . Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci. 2000; 57(8-9):1229-35. PMC: 11147023. DOI: 10.1007/pl00000762. View

2.
Sener M, Sener E, Tok A, Polat B, Cinar I, Polat H . Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine. Pharmacol Rep. 2012; 64(3):594-602. DOI: 10.1016/s1734-1140(12)70855-1. View

3.
Tangir J, Zelterman D, Ma W, Schwartz P . Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol. 2003; 101(2):251-7. DOI: 10.1016/s0029-7844(02)02508-5. View

4.
Farrell C, Heaven C, Beaver K, Maguire P . Identifying the concerns of women undergoing chemotherapy. Patient Educ Couns. 2004; 56(1):72-7. DOI: 10.1016/j.pec.2003.12.008. View

5.
Yucebilgin M, Terek M, Ozsaran A, Akercan F, Zekioglu O, Isik E . Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility. Aust N Z J Obstet Gynaecol. 2004; 44(1):6-9. DOI: 10.1111/j.1479-828X.2004.00143.x. View